2014
DOI: 10.1177/070674371405901208
|View full text |Cite
|
Sign up to set email alerts
|

Toward a Comprehensive Clinical Staging Model for Bipolar Disorder: Integrating the Evidence

Abstract: Objectives: To describe key findings relating to the natural history and heterogeneity of bipolar disorder (BD) relevant to the development of a unitary clinical staging model. Currently proposed staging models are briefly discussed, highlighting complementary findings, and a comprehensive staging model of BD is proposed integrating the relevant evidence.Method: A selective review of key published findings addressing the natural history, heterogeneity, and clinical staging models of BD are discussed. Results:T… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
63
1
3

Year Published

2015
2015
2020
2020

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 74 publications
(69 citation statements)
references
References 98 publications
2
63
1
3
Order By: Relevance
“…4,[51][52][53][54][55] Moreover, this neurocognitive heterogeneity in BD was reproduced in youth populations, 44 older-adults, 56 and even in healthy relatives. 57 On the other hand, the stability of cognitive performance along the lifespan suggests that deficits in the subgroup of patients with cognitive 60 Similarly, Duffy and colleagues in a series of publications showed that a subgroup of patients with BD manifest problems with cognition, emotional regulation, socialization, and neurodevelopment disorders in their premorbid stage (for a review see Duffy 61 ). In addition, the two large cohort studies performed in BD showed that both low and high levels of intelligence and school performance in youth are associated with an increased risk of later develop the disorder, which also might support the neurodevelopment abnormalities in a subgroup of patients.…”
Section: Discussionmentioning
confidence: 99%
“…4,[51][52][53][54][55] Moreover, this neurocognitive heterogeneity in BD was reproduced in youth populations, 44 older-adults, 56 and even in healthy relatives. 57 On the other hand, the stability of cognitive performance along the lifespan suggests that deficits in the subgroup of patients with cognitive 60 Similarly, Duffy and colleagues in a series of publications showed that a subgroup of patients with BD manifest problems with cognition, emotional regulation, socialization, and neurodevelopment disorders in their premorbid stage (for a review see Duffy 61 ). In addition, the two large cohort studies performed in BD showed that both low and high levels of intelligence and school performance in youth are associated with an increased risk of later develop the disorder, which also might support the neurodevelopment abnormalities in a subgroup of patients.…”
Section: Discussionmentioning
confidence: 99%
“…C‐peptide, insulin, MMP‐7, and peptide YY were also found to be changed in BD depressed patients, which suggests that these proteins could be trait markers for BD. Thus, application of individual biomarkers depends on the stage of the disease …”
Section: Biomarkersmentioning
confidence: 99%
“…Furthermore, staging models for BD have been proposed (Duffy, 2014;Vieta et al, 2011). In addition, emerging evidence indicates that individuals at later stages of BD may have more impaired cognitive and psychosocial functioning (Grande et al, 2014;Rosa et al, 2014).…”
Section: Introductionmentioning
confidence: 96%